Savara (SVRA) Non-Current Deferred Tax Liability (2011 - 2018)
Savara (SVRA) posted quarterly Non-Current Deferred Tax Liability of $2.5 million for Q3 2018, down 77.5% year-over-year from $11.3 million in Q3 2017, and down 0.78% quarter-over-quarter from $2.6 million in Q2 2018.
Savara (SVRA) Non-Current Deferred Tax Liability (2011 - 2018) Analysis & Trends
Savara (SVRA) has reported Non-Current Deferred Tax Liability for 8 consecutive years, with $2.5 million the latest figure, recorded in Q3 2018.
- In Q3 2018, Non-Current Deferred Tax Liability fell 77.5% year-over-year to $2.5 million; the TTM figure through Sep 2018 stood at $2.5 million (down 77.5% YoY), while the FY2017 annual figure was $7.2 million, up 211.54% from the prior year.
- Non-Current Deferred Tax Liability eased to $2.5 million in Q3 2018 per SVRA's latest filing, from $2.6 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $11.3 million in Q3 2017 and bottomed at $995000.0 in Q1 2017.
- Historically, Non-Current Deferred Tax Liability has averaged $4.1 million across 5 years, with a median of $3.4 million in 2014.
- Annual changes were most pronounced in 2017 — Non-Current Deferred Tax Liability jumped 230.88% — and 2018, when it slumped 77.5%.
- Savara's Non-Current Deferred Tax Liability stood at $3.4 million in 2014, then changed by 0.0% to $3.4 million in 2015, then plunged by 32.29% to $2.3 million in 2016, then soared by 211.54% to $7.2 million in 2017, then slumped by 64.71% to $2.5 million in 2018.
- Business Quant data shows SVRA's Non-Current Deferred Tax Liability at $2.5 million in Q3 2018, $2.6 million in Q2 2018, and $2.7 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Savara | 1.11 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 2.53 Mn |
| Sep 30, 2018 | 2.53 Mn |
| Jun 30, 2018 | 2.55 Mn |
| Jun 30, 2018 | 2.55 Mn |
| Mar 31, 2018 | 2.69 Mn |
| Mar 31, 2018 | 2.69 Mn |
| Dec 31, 2017 | 7.18 Mn |
| Dec 31, 2017 | 7.18 Mn |
| Sep 30, 2017 | 11.26 Mn |
| Sep 30, 2017 | 11.26 Mn |
| Jun 30, 2017 | 11.18 Mn |
| Jun 30, 2017 | 11.18 Mn |
| Mar 31, 2017 | 995,000.00 |
| Mar 31, 2017 | 995,000.00 |
| Dec 31, 2016 | 2.31 Mn |
| Dec 31, 2016 | 2.31 Mn |
| Sep 30, 2016 | 3.40 Mn |
| Sep 30, 2016 | 3.40 Mn |
| Jun 30, 2016 | 3.40 Mn |
| Jun 30, 2016 | 3.40 Mn |